Transcriptome Profiling of Cardiac Glycoside Treatment Reveals EGR1 and Downstream Proteins of MAPK/ERK Signaling Pathway in Human Breast Cancer Cells
Cardiac glycosides (CGs) constitute a group of steroid-like compounds renowned for their effectiveness in treating cardiovascular ailments. In recent times, there has been growing recognition of their potential use as drug leads in cancer treatment. In our prior research, we identified three highly...
Main Authors: | Honey Pavithran, Ranjith Kumavath, Preetam Ghosh |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-11-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/21/15922 |
Similar Items
-
Strophanthidin Attenuates MAPK, PI3K/AKT/mTOR, and Wnt/β-Catenin Signaling Pathways in Human Cancers
by: Dhanasekhar Reddy, et al.
Published: (2020-01-01) -
Peruvoside, a Cardiac Glycoside, Induces Primitive Myeloid Leukemia Cell Death
by: Qian Feng, et al.
Published: (2016-04-01) -
Repurposing Cardiac Glycosides: Drugs for Heart Failure Surmounting Viruses
by: Jan Škubník, et al.
Published: (2021-09-01) -
Polyphagous insect Olepa sps. feeding on cardenolide rich Calotropis gigantea (L.) leaves and detoxification mechanism involving GST
by: Krishnamanikumar Premachandran, et al.
Published: (2022-09-01) -
Emergence of Cardiac Glycosides as Potential Drugs: Current and Future Scope for Cancer Therapeutics
by: Ranjith Kumavath, et al.
Published: (2021-08-01)